Alliance Pharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Nick Sedgwick

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure7.2yrs
Board average tenureless than a year

Recent management updates

Recent updates

Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Sep 10
Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Is Alliance Pharma (LON:APH) A Risky Investment?

Jun 21
Is Alliance Pharma (LON:APH) A Risky Investment?

Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Feb 23
Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

Nov 21
Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

May 26
We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

Mar 24
Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

Sep 30
We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

May 28
An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Mar 30
Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Dec 24
Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

Nov 19
Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

CEO

Nick Sedgwick (52 yo)

less than a year

Tenure

Mr. Nicholas John Sedgwick, also known as Nick, is Chief Executive Officer and Director of Alliance Pharma plc from May 13, 2024. Sedgwick brings thirty years of consumer health experience across European,...


Leadership Team

NamePositionTenureCompensationOwnership
Andrew Franklin
CFO & Executive Director9.2yrsUK£310.18k0.036%
£ 86.9k
Nicholas Sedgwick
CEO & Directorless than a yearno datano data
Stephen Kidner
Chief Scientific Affairs Officerno datano datano data
Cora McCallum
Head of Investor Relations & Corporate Communicationsno datano datano data
Christodoulos Chrysanthou
Group General Counsel & Company Secretary7.2yrsno datano data
Alex Duggan
Chief Commercial & Corporate Development Officerno datano datano data
Julie Skinner
Chief People Officer1.8yrsno datano data
Chris Delafield
Global Marketing Head of Kelo-Cote7.8yrsno datano data
Rhodri Smith
Head of Sourcingno datano datano data

7.2yrs

Average Tenure

Experienced Management: APH's management team is seasoned and experienced (7.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Andrew Franklin
CFO & Executive Director9.2yrsUK£310.18k0.036%
£ 86.9k
Nicholas Sedgwick
CEO & Directorless than a yearno datano data
Martin Sutherland
Independent Non-Executive Director1.8yrsUK£48.22kno data
Richard Crispin Jones
Senior Independent Non-Executive Director5.8yrsUK£58.84k0.013%
£ 30.6k
Camillo Pane
Independent Non Executive Chairless than a yearno datano data
Kristof Neirynck
Independent Non-Executive Director2.9yrsUK£52.80kno data
Richard McKenzie
Independent Non-Executive Directorless than a yearUK£7.27kno data
Eva-Lotta Sjostedt
Independent Non-Executive Directorless than a yearUK£7.27kno data
Martin Camilo
Member of Supervisory Boardless than a yearno datano data

1.0yrs

Average Tenure

55yo

Average Age

Experienced Board: APH's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.